Research
Finally, a Vaccine for Cancer
NYT > Health · By Michael Barbaro, Nina Agrawal, Alex Stern, Chris Benderev, Eric Krupke, Carlos Prieto, Marion Lozano, Rowan Niemisto, Dan Powell & Alyssa Moxley ·
The Brief
- An experimental cancer vaccine has been found to prevent melanoma recurrence, according to a New York Times report dated 2026-11-16.
- Scientists hope the approach will not be the last of its kind, according to the same source.
- The source is a short podcast-episode summary, so trial design, sample size and results beyond this claim are not stated.
Why it matters
If the finding holds, it suggests vaccine-based approaches may help prevent cancer recurrence, a development science readers working on immunotherapy or oncology trials would want to track.
Who’s affected
- oncologists and cancer researchers
- melanoma patients and clinicians
- #cancer vaccine
- #melanoma
- #immunotherapy
- #oncology
- #recurrence
An experimental vaccine has been found to prevent recurrence of melanoma. Scientists hope it won’t be the last.